1. Home
  2. RXT vs EBS Comparison

RXT vs EBS Comparison

Compare RXT & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$1.02

Market Cap

481.5M

Sector

Technology

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.26

Market Cap

409.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
EBS
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.5M
409.5M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
RXT
EBS
Price
$1.02
$8.26
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$1.71
$12.00
AVG Volume (30 Days)
11.4M
906.1K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
125.83
EPS
N/A
0.93
Revenue
$2,685,700,000.00
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
$1.35
N/A
P/E Ratio
N/A
$8.66
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$4.02
52 Week High
$2.74
$14.06

Technical Indicators

Market Signals
Indicator
RXT
EBS
Relative Strength Index (RSI) 35.96 40.86
Support Level $0.39 $7.72
Resistance Level $1.22 $9.28
Average True Range (ATR) 0.19 0.29
MACD -0.13 0.11
Stochastic Oscillator 6.07 68.33

Price Performance

Historical Comparison
RXT
EBS

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: